Founders and Management

Saad Harti
President

Saad has started in the financial field, at Arthur Andersen. He later co-founded Altacare, a healthcare busi-
ness development firm active in more than 50 markets. Saad has pioneered medicine access program in
developing countries.
Saad is a co-founder of Legacy and is managing the company.

Geert Cauwenbergh, Ph.D.
Partner

Geert founded Barrier Therapeutics, a dermatology company in 2001. After bringing Barrier to success it
was acquired by Stiefel in 2008. Prior to founding Barrier, Geert was responsible for the worldwide
research and development of all skin care products for the Johnson & Johnson consumer companies. He is
a board member of several dermatology companies. He has authored more than 100 publications.
Geert is a shareholder of Legacy and acts as strategic and scientific advisor.

JiaWei Liu, Ph.D.
VP R&D

Active in international academic and pharmaceutical industry, JiaWei successfully developed quality research
projects in Chinese Academy of Sciences, Geneva and Lausanne University Hospitals. He was previously responsible
for new drug search & evaluation Asia at the Swiss drug development company Debiopharm Group.
He also engaged in teaching activities at Harvard Medical School in 2013 and 2014. As Legacy Healthcare’s
Vice President, he is in charge of the company’s R&D activities.

Michel Chretienne, Pharm D.
VP Quality

Michel has served as Pharmaceutical Director and Pharmacist in charge at Hoechst Marion Roussel
(Aventis) until 1999. Michel is involved in a number of professional and scientific societies such as the
French Association of Regulatory Affairs, Member of the Ethic Committee and Mediation of the French
pharmaceutical industry (CEMIP) etc.
Michel is responsible of the quality and manufacturing affairs of Legacy.